Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Impact of perioperative immunosuppressive medication on surgical outcome in Crohn's Disease (CD).

Eisner F, Küper MA, Ziegler F, Zieker D, Königsrainer A, Glatzle J.

Z Gastroenterol. 2014 May;52(5):436-40. doi: 10.1055/s-0033-1356347. Epub 2014 May 13.

PMID:
24824908
2.

Effect of perioperative immunosuppressive medication on early outcome in Crohn's disease patients.

Indar AA, Young-Fadok TM, Heppell J, Efron JE.

World J Surg. 2009 May;33(5):1049-52. doi: 10.1007/s00268-009-9957-x.

PMID:
19277774
3.

Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease.

Bafford AC, Powers S, Ha C, Kruse D, Gorfine SR, Chessin DB, Bauer JJ.

J Clin Gastroenterol. 2013 Jul;47(6):491-5. doi: 10.1097/MCG.0b013e3182677003.

PMID:
23090048
4.

Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.

Colombel JF, Loftus EV Jr, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ.

Am J Gastroenterol. 2004 May;99(5):878-83.

PMID:
15128354
5.

Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn's disease?

White EC, Melmed GY, Vasiliauskas E, Dubinsky M, Ippoliti A, McGovern D, Targan S, Fleshner P.

Dis Colon Rectum. 2012 May;55(5):563-8. doi: 10.1097/DCR.0b013e3182468961.

PMID:
22513435
6.

Outcomes of ileocolic resection and right hemicolectomies for Crohn's patients in comparison with non-Crohn's patients and the impact of perioperative immunosuppressive therapy with biologics and steroids on inpatient complications.

Mascarenhas C, Nunoo R, Asgeirsson T, Rivera R, Kim D, Hoedema R, Dujovny N, Luchtefeld M, Davis AT, Figg R.

Am J Surg. 2012 Mar;203(3):375-8; discussion 378. doi: 10.1016/j.amjsurg.2011.11.001.

PMID:
22364904
7.

Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates?

Canedo J, Lee SH, Pinto R, Murad-Regadas S, Rosen L, Wexner SD.

Colorectal Dis. 2011 Nov;13(11):1294-8. doi: 10.1111/j.1463-1318.2010.02469.x.

PMID:
20969715
8.

Clinical features and predictors of clinical outcomes in Korean patients with Crohn's disease: a Korean association for the study of intestinal diseases multicenter study.

Moon CM, Park DI, Kim ER, Kim YH, Lee CK, Lee SH, Kim JH, Huh KC, Jung SA, Yoon SM, Song HJ, Jang HJ, Kim YS, Lee KM, Shin JE.

J Gastroenterol Hepatol. 2014 Jan;29(1):74-82. doi: 10.1111/jgh.12369.

PMID:
23981141
9.

Thiopurine therapy is associated with postoperative intra-abdominal septic complications in abdominal surgery for Crohn's disease.

Myrelid P, Olaison G, Sjödahl R, Nyström PO, Almer S, Andersson P.

Dis Colon Rectum. 2009 Aug;52(8):1387-94. doi: 10.1007/DCR.0b013e3181a7ba96.

PMID:
19617749
10.

Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005.

Herrinton LJ, Liu L, Fireman B, Lewis JD, Allison JE, Flowers N, Hutfless S, Velayos FS, Abramson O, Altschuler A, Perry GS.

Gastroenterology. 2009 Aug;137(2):502-11. doi: 10.1053/j.gastro.2009.04.063. Epub 2009 May 13.

PMID:
19445944
11.

Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn's disease.

Kanazawa A, Yamana T, Okamoto K, Sahara R.

Dis Colon Rectum. 2012 Sep;55(9):957-62. doi: 10.1097/DCR.0b013e3182617716.

PMID:
22874602
12.

The impact of obesity on outcomes following major surgery for Crohn's disease: an American College of Surgeons National Surgical Quality Improvement Program assessment.

Causey MW, Johnson EK, Miller S, Martin M, Maykel J, Steele SR.

Dis Colon Rectum. 2011 Dec;54(12):1488-95. doi: 10.1097/DCR.0b013e3182342ccb.

PMID:
22067176
13.

Clinical literature review of 1858 Crohn's disease cases requiring surgery in China.

Peng QH, Wang YF, He MQ, Zhang C, Tang Q.

World J Gastroenterol. 2015 Apr 21;21(15):4735-43. doi: 10.3748/wjg.v21.i15.4735. Review.

14.

Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease.

El-Hussuna A, Andersen J, Bisgaard T, Jess P, Henriksen M, Oehlenschlager J, Thorlacius-Ussing O, Olaison G.

Scand J Gastroenterol. 2012 Jun;47(6):662-8. doi: 10.3109/00365521.2012.660540. Epub 2012 Apr 10.

PMID:
22486168
15.

[Crohn disease: resection therapy over the course of two decades].

Lorenz D, Lorenz U, Hagmüller E, Saeger HD.

Zentralbl Chir. 1993;118(3):127-33; discussion 133-4. German.

PMID:
8484285
16.

Phenotypic features of Crohn's disease associated with failure of medical treatment.

Moran GW, Dubeau MF, Kaplan GG, Yang H, Seow CH, Fedorak RN, Dieleman LA, Barkema HW, Ghosh S, Panaccione R; Alberta Inflammatory Bowel Disease Consortium.

Clin Gastroenterol Hepatol. 2014 Mar;12(3):434-42.e1. doi: 10.1016/j.cgh.2013.08.026. Epub 2013 Aug 24.

PMID:
23978351
18.

["Fast-track" and elective, laparoscopic colo-rectal surgery].

Widmaier U, Karrer M, Schoenberg MH.

Zentralbl Chir. 2007 Aug;132(4):342-8; discussion 348-9. German.

PMID:
17724638
19.

[Recurrence of Crohn's disease after surgery--causes and risks].

Mirow L, Hauenschild L, Hildebrand P, Kleemann M, Keller R, Franke C, Roblick UJ, Bruch HP, Kujath P.

Zentralbl Chir. 2008 Apr;133(2):182-7. doi: 10.1055/s-2008-1004743. German.

PMID:
18415909
20.

[Postoperative morbidity after bowel resections in patients with Crohn's disease: risk, management strategies, prevention].

Iesalnieks I, Dederichs F, Kilger A, Schlitt HJ, Agha A.

Z Gastroenterol. 2012 Jun;50(6):595-600. doi: 10.1055/s-0031-1299462. Epub 2012 Jun 1. Review. German.

PMID:
22660995

Supplemental Content

Support Center